{"denoms":[{"counts":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"216"}],"units":"Participants"}],"groups":[{"description":"Arm 1: Methotrexate 30 mg/m2 IM weekly","id":"BG000","title":"Arm 1: Methotrexate 30 mg/m2 IM Weekly"},{"description":"Arm 2: Dactinomycin 1.25 mg/m2 IV push every 2 weeks","id":"BG001","title":"Arm 2: Dactinomycin 1.25 mg/m2 IV Push Every 2 Weeks"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.9","value":"28.8"},{"groupId":"BG001","spread":"8.6","value":"30.4"},{"groupId":"BG002","spread":"8.3","value":"29.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"216"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}],"populationDescription":"Eligible participants"}